Isoniazid-resistant tuberculosis treatment with first-line drugs
Journal
The Lancet Infectious Diseases
Journal Volume
17
Journal Issue
3
Pages
259-260
Date Issued
2017
Author(s)
SDGs
Other Subjects
ethambutol; isoniazid; pyrazinamide; rifampicin; antibiotic resistance; drug treatment failure; high risk patient; human; Letter; lung disease; lung tuberculosis; major clinical study; priority journal; relapse; sputum smear; Taiwan; treatment duration; treatment outcome; world health organization
Publisher
Lancet Publishing Group
Type
letter